Zoe Assaf

Senior Scientist and ctDNA enthusiast in the Data Science Group of Genentech's Oncology Biomarker Development Department

[Tom Powles @tompowles1]

ctDNA guides adjuvant immune therapy in UC. Combining different biomarker platforms (tissue and circulating) increases our understanding. IMVIGOR011 tests ctDNA prospectively and is enrolling @OncoBellmunt @SanjMariathasan https://t.co/WZm2CpAXKt

[Zoe Assaf @ZoeJuneAssaf]

@Barzin_ @SanjMariathasan @genentech Thank you Barzin!

[Zoe Assaf @ZoeJuneAssaf]

Super excited our IMvigor010 ctDNA paper just came out in Nature!

https://t.co/ufyXJTBx1h

We show that ctDNA testing after surgery can identify bladdercancer patients with residual disease who are likely to benefit from additional adjuvant immunotherapy - groundbreaking work!

[Zoe Assaf @ZoeJuneAssaf]

Awesome talk!"@ATJCagan: M.Przeworski: Balancing selection on ABO variation precedes its expression in blood #smbe13”

[Zoe Assaf @ZoeJuneAssaf]

@fabbyrob @joshhough01 @PetrovADmitri Thank you! It was a real pleasure to speak to everyone.

[Zoe Assaf @ZoeJuneAssaf]

At #smbe13 come check out my poster! Staggered Sweeps: How Recessive Deleterious Mutations Interfere With Adaptation. Poster # 001!

[Zoe Assaf @ZoeJuneAssaf]

@PetrovADmitri thanks Dmitri! :)

[Zoe Assaf @ZoeJuneAssaf]

.@pleunipennings Pleuni won the film festival!

[Zoe Assaf @ZoeJuneAssaf]

My presentation on Staggered Sweeps got runner-up (i.e. a certificate) for the Hamilton Award! #evol2013

[Zoe Assaf @ZoeJuneAssaf]

@oanacarja Hahah, I would be so much more lost without you =P The twitter app is surprisingly unintuitive if you're not in the loop!

[Zoe Assaf @ZoeJuneAssaf]

@PetrovADmitri @pleunipennings Here it is: "Why do slave ants kill slavemakers?" http://t.co/buvPfoDUms

[Zoe Assaf @ZoeJuneAssaf]

Pleuni's @pleunipennings movie rocked the #evol2013 film festival!

[Zoe Assaf @ZoeJuneAssaf]

@PetrovADmitri @jrossibarra @Graham_Coop @kj_gilbert @yanivbrandvain @oanacarja Thanks everyone for coming out to my presentation! #evol2013